TNB-738

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTNB-738

Drug Alias NameTNB-738

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-CD38

TargetsLymphocyte differentiation antigen CD38

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTeneoFour Inc

China Registration ClassN/A

Develop Information

Active CompaniesTeneoFour Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A